Saudi Aramco Base Oil Company - Luberef Valuation
Is 2223 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 2223 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 2223 (SAR147.6) is trading below our estimate of fair value (SAR262.34)
Significantly Below Fair Value: 2223 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2223?
Other financial metrics that can be useful for relative valuation.
| What is 2223's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | ر.س25.25b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.7x |
| Enterprise Value/EBITDA | 13.3x |
| PEG Ratio | 3x |
Price to Earnings Ratio vs Peers
How does 2223's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 78.3x | ||
2310 Sahara International Petrochemical | 19.3x | 17.0% | ر.س22.6b |
2060 National Industrialization | 51.2x | 39.0% | ر.س9.0b |
2330 Advanced Petrochemical | 61.7x | 48.1% | ر.س10.4b |
2010 Saudi Basic Industries | 181.2x | 58.3% | ر.س236.7b |
2223 Saudi Aramco Base Oil Company - Luberef | 16.5x | 5.5% | ر.س25.2b |
Price-To-Earnings vs Peers: 2223 is good value based on its Price-To-Earnings Ratio (16.5x) compared to the peer average (78.3x).
Price to Earnings Ratio vs Industry
How does 2223's PE Ratio compare vs other companies in the Asian Chemicals Industry?
Price-To-Earnings vs Industry: 2223 is good value based on its Price-To-Earnings Ratio (16.5x) compared to the Asian Chemicals industry average (22.2x).
Price to Earnings Ratio vs Fair Ratio
What is 2223's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 16.5x |
| Fair PE Ratio | 23x |
Price-To-Earnings vs Fair Ratio: 2223 is good value based on its Price-To-Earnings Ratio (16.5x) compared to the estimated Fair Price-To-Earnings Ratio (23x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | ر.س147.60 | ر.س152.70 +3.5% | 8.0% | ر.س166.00 | ر.س132.50 | n/a | 5 |
| Apr ’25 | ر.س157.40 | ر.س148.10 -5.9% | 10.1% | ر.س166.00 | ر.س131.00 | n/a | 5 |
| Mar ’25 | ر.س168.00 | ر.س137.50 -18.2% | 4.2% | ر.س147.00 | ر.س131.00 | n/a | 5 |
| Feb ’25 | ر.س146.80 | ر.س138.75 -5.5% | 4.2% | ر.س147.00 | ر.س131.00 | n/a | 4 |
| Jan ’25 | ر.س145.00 | ر.س135.50 -6.6% | 2.5% | ر.س140.00 | ر.س131.00 | n/a | 4 |
| Dec ’24 | ر.س137.20 | ر.س134.70 -1.8% | 2.3% | ر.س140.00 | ر.س131.00 | n/a | 5 |
| Nov ’24 | ر.س130.20 | ر.س133.60 +2.6% | 1.3% | ر.س136.00 | ر.س131.00 | n/a | 5 |
| Oct ’24 | ر.س149.00 | ر.س132.60 -11.0% | 1.1% | ر.س134.50 | ر.س131.00 | n/a | 5 |
| Sep ’24 | ر.س146.40 | ر.س132.60 -9.4% | 1.1% | ر.س134.50 | ر.س131.00 | n/a | 5 |
| Aug ’24 | ر.س148.40 | ر.س125.80 -15.2% | 8.6% | ر.س134.50 | ر.س105.00 | n/a | 5 |
| Jul ’24 | n/a | ر.س123.30 0% | 8.7% | ر.س134.50 | ر.س105.00 | n/a | 5 |
| Jun ’24 | ر.س131.60 | ر.س121.00 -8.1% | 9.0% | ر.س134.50 | ر.س105.00 | n/a | 4 |
| May ’24 | ر.س114.80 | ر.س112.75 -1.8% | 4.0% | ر.س116.00 | ر.س105.00 | n/a | 4 |
| Apr ’24 | ر.س111.40 | ر.س112.75 +1.2% | 4.0% | ر.س116.00 | ر.س105.00 | ر.س157.40 | 4 |
| Mar ’24 | ر.س107.40 | ر.س112.75 +5.0% | 4.0% | ر.س116.00 | ر.س105.00 | ر.س168.00 | 4 |
| Feb ’24 | ر.س98.60 | ر.س111.50 +13.1% | 2.2% | ر.س114.00 | ر.س109.00 | ر.س146.80 | 2 |
Analyst Forecast: Target price is less than 20% higher than the current share price.